T 0617/07 (Monoclonal NGF-antagonist antibodies/LAY LINE) of 4.8.2009

European Case Law Identifier: ECLI:EP:BA:2009:T061707.20090804
Date of decision: 04 August 2009
Case number: T 0617/07
Application number: 00935482.0
IPC class: C07K 16/28
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 63 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as NGF-antagonist molecules
Applicant name: Lay Line Genomics SpA
Opponent name: Astrazeneca UK Limited
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention Art 54
European Patent Convention Art 56
European Patent Convention Art 83
European Patent Convention Art 123(2)
European Patent Convention Art 123(3)
Keywords: Added matter, extension of protection (no)
Sufficiency of disclosure, novelty, inventive step (yes)
Catchwords:

-

Cited decisions:
T 0226/85
T 0409/91
T 0694/92
T 0309/06
Citing decisions:
T 0596/11
T 0941/16

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t070617eu1.html

Date retrieved: 17 May 2021

12 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Case Law Book: II Conditions to be met by an Application

General Case Law